Cost-effectiveness evaluation of abiraterone in the treatment of patients with castration-resistant prostate cancer who previously received docetaxel.
Akhil Chopra
No relevant relationships to disclose
Stefan Gluck
No relevant relationships to disclose
Alberto J. Montero
No relevant relationships to disclose
Kiran Kumar Venkata Raja Avancha
No relevant relationships to disclose
Gilberto Lopes
No relevant relationships to disclose